Eric Suarez, research program coordinator for University of Florida Croc Docs, holds a female python during a research trip to collect python eggs on Tuesday, June 30, 2026, from a nest the scientists ...

The South Florida Water Management District's Python Elimination Program rewards hunters for removing the invasive snakes. In May 2026, contracted hunters eliminated 315 python eggs from the ...

Replimune (REPL) won over the FDA to submit a marketing application for its lead asset RP1 for the third time despite previous rejections, thanks to the intervention of White House officials, The Wall ...

The website for the popular JDownloader download manager was compromised earlier this week to distribute malicious Windows and Linux installers, with the Windows payload found deploying a Python-based ...

The ACS Approval Program promotes excellence in chemistry education for undergraduate students through approval of baccalaureate chemistry programs. ACS-approved programs offer a broad-based and ...

Everged is rolling out a new program aimed at fixing one of the EV industry’s most persistent problems: broken and outdated chargers that never seem to get repaired. The Vienna, Virginia-based energy ...

No more waiting on slow-loading modules or wasting time on ad hoc workarounds: Python 3.15’s new ‘lazy imports’ mechanism has you covered. When you import a module in Python, the module’s code must be ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, deeply weird. Credit...Illustration by Pablo Delcan and Danielle Del Plato ...

Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...